Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
皮膚免疫、皮膚の恒常性維持、アトピー性皮膚炎・乾癬などの皮膚疾患
Launch date令和7年12月3日～5日（実績：学会開催期間）
What the company reported numerically
Quantitative Effects
黄色ブドウ球菌および緑膿菌のバイオフィルム形成を阻害する複数の植物抽出物、ならびにマクロファージの活性化を直接抑制する植物抽出物を発見（数値なし）
Relationship between the counterparty and the company
IVY COSMETICS CORPORATION4918
Relationship with the Company
Joint Research
CounterpartyYamaguchi University
Impact on Business Performance
At this time, there is no impact on results for the current fiscal year
The company does not address Contract Value / Offering price.
Source (materials cited by the company)
第48回日本分子生物学会年会
| Item | Details |
|---|---|
| Counterparty | Yamaguchi University |
| Relationship with the Company | Joint Research |
| Launch date | 令和7年12月3日～5日（実績：学会開催期間） |
| Applicable area | 皮膚免疫、皮膚の恒常性維持、アトピー性皮膚炎・乾癬などの皮膚疾患 |
| Quantitative Effects | 黄色ブドウ球菌および緑膿菌のバイオフィルム形成を阻害する複数の植物抽出物、ならびにマクロファージの活性化を直接抑制する植物抽出物を発見（数値なし） |
| Impact on Business Performance | At this time, there is no impact on results for the current fiscal year |
| Source | 第48回日本分子生物学会年会 |
Items this document does not state (11)
Names of Products / Services CoveredCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage history
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.第48回日本分子生物学会年会で研究発表を行ったため。会社は、現時点では当期業績への影響はないとしている。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.